Listed

Lexicon Pharmaceuticals, Inc.

LXRXNasdaqCIK 1062822HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$692.0k, Q2 FY2026
Operating income−$26.5m, Q2 FY2026
Net income−$31.8m, Q2 FY2026
Lexicon Pharmaceuticals, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.1Revenue, Q3 FY2023, three months to 2023-09-30$148.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure0.7Revenue, Q4 FY2023, three months to 2023-12-31$672.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-07, accession 0001062822-25-000013. Derived: 12-month figure less the 9-month figure.Report this figure1.1Revenue, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure1.6Revenue, Q2 FY2024, three months to 2024-06-30$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure1.7Revenue, Q3 FY2024, three months to 2024-09-30$1.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure1.6Revenue, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-07, accession 0001062822-25-000013. Derived: 12-month figure less the 9-month figure.Report this figure1.3Revenue, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure28.9Revenue, Q2 FY2025, three months to 2025-06-30$28.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure14.2Revenue, Q3 FY2025, three months to 2025-09-30$14.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure5.5Revenue, Q4 FY2025, three months to 2025-12-31$5.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure21.1Revenue, Q1 FY2026, three months to 2026-03-31$21.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure0.7Revenue, Q2 FY2026, three months to 2026-06-30$692.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Cost of revenue$m0.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$7.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure0.1Cost of revenue, Q4 FY2023, three months to 2023-12-31$70.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2024, three months to 2024-03-31$31.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure0.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$166.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure0.1Cost of revenue, Q3 FY2024, three months to 2024-09-30$71.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure0.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$348.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$30.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$33.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$10.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure0.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$201.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure0.1Cost of revenue, Q1 FY2026, three months to 2026-03-31$108.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$39.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Research and development$m17.6Research and development, Q3 FY2023, three months to 2023-09-30$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure14.8Research and development, Q4 FY2023, three months to 2023-12-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure14.4Research and development, Q1 FY2024, three months to 2024-03-31$14.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure17.6Research and development, Q2 FY2024, three months to 2024-06-30$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure25.8Research and development, Q3 FY2024, three months to 2024-09-30$25.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure26.7Research and development, Q4 FY2024, three months to 2024-12-31$26.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure15.3Research and development, Q1 FY2025, three months to 2025-03-31$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure15.7Research and development, Q2 FY2025, three months to 2025-06-30$15.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure18.8Research and development, Q3 FY2025, three months to 2025-09-30$18.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure11.3Research and development, Q4 FY2025, three months to 2025-12-31$11.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure12.8Research and development, Q1 FY2026, three months to 2026-03-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure17.4Research and development, Q2 FY2026, three months to 2026-06-30$17.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Selling, general and administrative$m32.2Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$32.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure32.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$32.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure32.1Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$32.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure39.2Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$39.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure39.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$39.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure32.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$32.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure11.6Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$11.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure9.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$9.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure7.6Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$7.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure8.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$8.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure9.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$9.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure9.8Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$9.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Operating income$m(49.6)Operating income, Q3 FY2023, three months to 2023-09-30−$49.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure(46.7)Operating income, Q4 FY2023, three months to 2023-12-31−$46.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(45.3)Operating income, Q1 FY2024, three months to 2024-03-31−$45.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure(55.4)Operating income, Q2 FY2024, three months to 2024-06-30−$55.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure(63.7)Operating income, Q3 FY2024, three months to 2024-09-30−$63.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure(32.7)Operating income, Q4 FY2024, three months to 2024-12-31−$32.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(25.7)Operating income, Q1 FY2025, three months to 2025-03-31−$25.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure3.7Operating income, Q2 FY2025, three months to 2025-06-30$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure(12.2)Operating income, Q3 FY2025, three months to 2025-09-30−$12.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure(14.8)Operating income, Q4 FY2025, three months to 2025-12-31−$14.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Operating income, Q1 FY2026, three months to 2026-03-31−$996.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure(26.5)Operating income, Q2 FY2026, three months to 2026-06-30−$26.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Interest expense$m3.9Interest expense, Q3 FY2023, three months to 2023-09-30$3.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(50.5)Net income, Q3 FY2023, three months to 2023-09-30−$50.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure(49.8)Net income, Q4 FY2023, three months to 2023-12-31−$49.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(48.4)Net income, Q1 FY2024, three months to 2024-03-31−$48.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure(53.4)Net income, Q2 FY2024, three months to 2024-06-30−$53.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure(64.8)Net income, Q3 FY2024, three months to 2024-09-30−$64.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure(33.8)Net income, Q4 FY2024, three months to 2024-12-31−$33.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(25.3)Net income, Q1 FY2025, three months to 2025-03-31−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure3.3Net income, Q2 FY2025, three months to 2025-06-30$3.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure(12.8)Net income, Q3 FY2025, three months to 2025-09-30−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure(15.5)Net income, Q4 FY2025, three months to 2025-12-31−$15.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(1.0)Net income, Q1 FY2026, three months to 2026-03-31−$1.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure(31.8)Net income, Q2 FY2026, three months to 2026-06-30−$31.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Diluted EPS$ per share(0.21)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure(0.17)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure(0.18)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure0.01Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure(0.04)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figurenot reported0.00Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Basic EPS$ per share(0.21)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figurenot reported(0.20)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure(0.17)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure(0.18)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figurenot reported(0.07)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure0.01Basic EPS, Q2 FY2025, three months to 2025-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure(0.04)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figurenot reported0.00Basic EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure(0.07)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure

Balance sheet

Cash and equivalents$40.9m, Q2 FY2026
Long-term debt$51.4m, Q2 FY2026
Shareholders' equity$174.5m, Q2 FY2026
Lexicon Pharmaceuticals, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m21.1Cash and equivalents, Q3 FY2023, at 2023-09-30$21.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure22.5Cash and equivalents, FY2023, at 2023-12-31$22.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure96.5Cash and equivalents, Q1 FY2024, at 2024-03-31$96.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure35.6Cash and equivalents, Q2 FY2024, at 2024-06-30$35.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure34.6Cash and equivalents, Q3 FY2024, at 2024-09-30$34.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure66.7Cash and equivalents, FY2024, at 2024-12-31$66.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure62.9Cash and equivalents, Q1 FY2025, at 2025-03-31$62.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure21.4Cash and equivalents, Q2 FY2025, at 2025-06-30$21.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure49.7Cash and equivalents, Q3 FY2025, at 2025-09-30$49.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure34.3Cash and equivalents, FY2025, at 2025-12-31$34.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure38.1Cash and equivalents, Q1 FY2026, at 2026-03-31$38.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure40.9Cash and equivalents, Q2 FY2026, at 2026-06-30$40.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Current assets$m223Current assets, Q3 FY2023, at 2023-09-30$223.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure177Current assets, FY2023, at 2023-12-31$176.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure365Current assets, Q1 FY2024, at 2024-03-31$364.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure321Current assets, Q2 FY2024, at 2024-06-30$320.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure269Current assets, Q3 FY2024, at 2024-09-30$268.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure246Current assets, FY2024, at 2024-12-31$246.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure246Current assets, Q1 FY2025, at 2025-03-31$245.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure145Current assets, Q2 FY2025, at 2025-06-30$145.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure123Current assets, Q3 FY2025, at 2025-09-30$122.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure102Current assets, FY2025, at 2025-12-31$101.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure186Current assets, Q1 FY2026, at 2026-03-31$186.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure197Current assets, Q2 FY2026, at 2026-06-30$196.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Total assets$m276Total assets, Q3 FY2023, at 2023-09-30$276.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure229Total assets, FY2023, at 2023-12-31$229.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure417Total assets, Q1 FY2024, at 2024-03-31$417.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure373Total assets, Q2 FY2024, at 2024-06-30$373.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure321Total assets, Q3 FY2024, at 2024-09-30$321.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure298Total assets, FY2024, at 2024-12-31$298.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure298Total assets, Q1 FY2025, at 2025-03-31$297.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure226Total assets, Q2 FY2025, at 2025-06-30$225.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure206Total assets, Q3 FY2025, at 2025-09-30$205.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure185Total assets, FY2025, at 2025-12-31$185.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure269Total assets, Q1 FY2026, at 2026-03-31$268.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure250Total assets, Q2 FY2026, at 2026-06-30$250.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Current liabilities$m32.3Current liabilities, Q3 FY2023, at 2023-09-30$32.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure31.5Current liabilities, FY2023, at 2023-12-31$31.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure23.4Current liabilities, Q1 FY2024, at 2024-03-31$23.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure27.9Current liabilities, Q2 FY2024, at 2024-06-30$27.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure36.0Current liabilities, Q3 FY2024, at 2024-09-30$36.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure45.2Current liabilities, FY2024, at 2024-12-31$45.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure111Current liabilities, Q1 FY2025, at 2025-03-31$110.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure34.8Current liabilities, Q2 FY2025, at 2025-06-30$34.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure21.7Current liabilities, Q3 FY2025, at 2025-09-30$21.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure20.9Current liabilities, FY2025, at 2025-12-31$20.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure9.9Current liabilities, Q1 FY2026, at 2026-03-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure14.7Current liabilities, Q2 FY2026, at 2026-06-30$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Total liabilities$m137Total liabilities, Q3 FY2023, at 2023-09-30$137.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure136Total liabilities, FY2023, at 2023-12-31$136.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure128Total liabilities, Q1 FY2024, at 2024-03-31$128.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure133Total liabilities, Q2 FY2024, at 2024-06-30$133.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure143Total liabilities, Q3 FY2024, at 2024-09-30$142.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure152Total liabilities, FY2024, at 2024-12-31$152.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure175Total liabilities, Q1 FY2025, at 2025-03-31$174.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure96.1Total liabilities, Q2 FY2025, at 2025-06-30$96.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure85.8Total liabilities, Q3 FY2025, at 2025-09-30$85.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure77.4Total liabilities, FY2025, at 2025-12-31$77.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure66.0Total liabilities, Q1 FY2026, at 2026-03-31$66.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure75.5Total liabilities, Q2 FY2026, at 2026-06-30$75.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Long-term debt$m99.3Long-term debt, Q3 FY2023, at 2023-09-30$99.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure99.5Long-term debt, FY2023, at 2023-12-31$99.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure99.9Long-term debt, Q1 FY2024, at 2024-03-31$99.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure99.5Long-term debt, Q2 FY2024, at 2024-06-30$99.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure99.9Long-term debt, Q3 FY2024, at 2024-09-30$99.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure100Long-term debt, FY2024, at 2024-12-31$100.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure58.6Long-term debt, Q1 FY2025, at 2025-03-31$58.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure56.1Long-term debt, Q2 FY2025, at 2025-06-30$56.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure56.5Long-term debt, Q3 FY2025, at 2025-09-30$56.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure49.4Long-term debt, FY2025, at 2025-12-31$49.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure49.7Long-term debt, Q1 FY2026, at 2026-03-31$49.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure51.4Long-term debt, Q2 FY2026, at 2026-06-30$51.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure42.1Current portion of debt, Q1 FY2025, at 2025-03-31$42.1m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figurenot reportednot reported4.6Current portion of debt, FY2025, at 2025-12-31$4.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure0.0Current portion of debt, Q1 FY2026, at 2026-03-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure0.0Current portion of debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure
Shareholders' equity$m140Shareholders' equity, Q3 FY2023, at 2023-09-30$139.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure93.1Shareholders' equity, FY2023, at 2023-12-31$93.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-07, accession 0001062822-25-000013.Report this figure289Shareholders' equity, Q1 FY2024, at 2024-03-31$288.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure240Shareholders' equity, Q2 FY2024, at 2024-06-30$240.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure179Shareholders' equity, Q3 FY2024, at 2024-09-30$178.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure146Shareholders' equity, FY2024, at 2024-12-31$145.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001062822-26-000050.Report this figure123Shareholders' equity, Q1 FY2025, at 2025-03-31$123.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure129Shareholders' equity, Q2 FY2025, at 2025-06-30$129.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure120Shareholders' equity, Q3 FY2025, at 2025-09-30$120.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure108Shareholders' equity, FY2025, at 2025-12-31$107.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure203Shareholders' equity, Q1 FY2026, at 2026-03-31$202.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure175Shareholders' equity, Q2 FY2026, at 2026-06-30$174.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure

Cash flow

Operating cash flow−$9.2m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Share repurchases$0, Q4 FY2024
Lexicon Pharmaceuticals, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(41.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$41.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001062822-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure(50.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$50.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(55.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$55.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure(48.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$48.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001628280-25-038340. Derived: 6-month figure less the 3-month figure.Report this figure(53.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$53.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001062822-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure(21.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$21.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(43.8)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$43.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure17.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001062822-26-000117. Derived: 6-month figure less the 3-month figure.Report this figure(23.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$23.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001062822-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure(17.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure(14.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure(9.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001062822-26-000117. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001062822-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure0.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$250.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001628280-25-038340. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$307.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001062822-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2024, three months to 2024-12-31$474.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001062822-25-000054. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001062822-26-000050. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Share repurchases$m0.0Share repurchases, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001062822-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-07, accession 0001062822-25-000013. Derived: 12-month figure less the 9-month figure.Report this figure1.7Share repurchases, Q1 FY2024, three months to 2024-03-31$1.7m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-08-02, accession 0001062822-24-000046. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-13, accession 0001062822-24-000060. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2025-03-07, accession 0001062822-25-000013. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)437.65m, Q2 FY2026
Lexicon Pharmaceuticals, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares175Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30174,904,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001062822-23-000058.Report this figure189Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31189,014,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001062822-24-000024.Report this figure205Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30204,783,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-02, accession 0001062822-24-000046.Report this figure245Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30244,925,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0001062822-24-000060.Report this figure245Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31245,390,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001062822-25-000029.Report this figure311Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30310,836,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001628280-25-038340.Report this figure361Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30361,492,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure362Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31362,073,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure364Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30363,570,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure363Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30363,399,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001062822-25-000054.Report this figure400Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31400,240,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001062822-26-000101.Report this figure438Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30437,653,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure

Shares outstanding: 444.96mShares outstanding, period not labelled, at 2026-08-03444,955,934 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001062822-26-000117.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.